This is a different type of heart lining problem. It's not caused by germs. Instead, a blood clot forms on the heart lining, sometimes due to certain health conditions that make blood clot more easily. It's less common than the bacterial type.
Every report comes from a Lived member, sent anonymously.
Have you tried Lovenox (Enoxaparin) for Non-Infective Endocarditis?
Non-infective endocarditis, usually called nonbacterial thrombotic endocarditis or marantic endocarditis, is a rare condition in which small clumps of clotted blood form on the heart valves. These growths, called vegetations, look much like the ones seen in the more familiar infective endocarditis, but they contain no bacteria or other germs. They develop in people whose blood clots too easily because of another serious illness, most often cancer or an autoimmune disease such as lupus. When the condition occurs with lupus, it is also known as Libman-Sacks endocarditis. The vegetations usually do not damage the valve enough to cause symptoms of their own. The danger is that they are loosely attached and crumble easily, so pieces can break off and travel in the bloodstream. These fragments, called emboli, can block arteries supplying the brain, heart, kidneys, intestines or limbs. A stroke, often several small strokes at once, is the most common way the condition first comes to light.
The underlying problem is a hypercoagulable state, meaning the blood is primed to clot more readily than normal. Cancer is the most common association. The risk is highest with adenocarcinomas, cancers that start in gland-forming tissue such as the lung, ovary, bile ducts or prostate, and pancreatic cancer in particular. Sometimes the valve problem is found before the cancer itself has been diagnosed. Autoimmune conditions are the other major group. Lupus (systemic lupus erythematosus) and antiphospholipid syndrome, an immune disorder in which antibodies make the blood clot abnormally, are the best known. Rheumatoid arthritis, some blood cancers, severe burns and, in reported cases, COVID-19 have also been linked. Having one of these illnesses does not mean someone will develop the condition; it remains uncommon even among people at higher risk.
There is no single test that confirms non-infective endocarditis. It is usually suspected when someone has a stroke or another blocked artery without the usual explanation, particularly if they have cancer or an autoimmune disease. Brain MRI can add a clue: emboli from these vegetations tend to cause many small strokes of different sizes scattered across both sides of the brain. The vegetations are found with an echocardiogram, an ultrasound of the heart. The standard version is done through the chest wall and can miss small growths. When suspicion remains, a transesophageal echocardiogram follows: a thin ultrasound probe is passed down the numbed throat into the esophagus, which sits just behind the heart, giving a much clearer view of the valves. On imaging, sterile and infected vegetations look the same, so ruling out infection is the most important step. Repeated blood cultures, which try to grow bacteria from the blood, and tests for organisms that are hard to culture need to come back negative. This matters because the treatments differ: blood thinners are central here but can cause dangerous bleeding in the brain when the cause is infection. Blood tests for clotting problems and antiphospholipid antibodies, and cancer screening when no cause is known, help identify the illness behind it.
Treatment has two aims: stopping more clots from breaking off, and treating the illness that caused them. No clinical trials have tested specific treatments, so care is based on case series and expert experience, usually coordinated among heart specialists and the cancer, rheumatology or blood specialists treating the underlying disease. Blood thinners (anticoagulants) are the main treatment. Heparin, given as a continuous drip in hospital or as low-molecular-weight heparin injections under the skin, is generally preferred, especially when cancer is the cause. For people with lupus or antiphospholipid syndrome, warfarin, a blood thinner taken by mouth, is the usual long-term choice after an initial period of heparin. Newer oral blood thinners called direct oral anticoagulants, such as apixaban or rivaroxaban, are not recommended in antiphospholipid syndrome because they have been linked to more clots there, and their role in cancer-related cases is still uncertain. If a stroke has occurred, doctors check with a brain scan that it has not bled before starting a blood thinner. The central trade-off is bleeding risk, weighed carefully in people whose illness already disturbs clotting. Treating the underlying cancer or autoimmune disease is essential, though it is not known to dissolve vegetations that are already present. Heart valve surgery is uncommon. It is considered case by case, mainly when clots keep breaking off despite blood thinners, when a large, mobile vegetation poses a high risk, or when the valve is badly damaged or heart failure develops.
The outlook depends largely on the illness behind the condition. Many people who develop it have advanced cancer, and in that case the cancer usually shapes the course more than the heart valves do. People whose condition is related to lupus or antiphospholipid syndrome may live with it for years, but strokes can leave lasting effects on thinking, movement or speech. In one group of 30 people with lupus followed for six years, about a quarter had another stroke and a similar share had lasting problems with thinking. New clots can still occur on treatment, so blood thinners are often continued for a long time. The right length of treatment is not settled; it generally depends on whether the cause is still active, and people with antiphospholipid syndrome usually stay on treatment indefinitely. Follow-up looks for bleeding, a low platelet count and signs of new emboli, and repeat echocardiograms may show whether the vegetations are shrinking. Warfarin needs regular INR checks (the international normalized ratio, a blood test of how long blood takes to clot) to keep the dose in a range that prevents clots without causing bleeding.
If you have cancer or an autoimmune disease and are told a growth has been seen on a heart valve, ask how infection will be ruled out and whether a fuller evaluation is needed. While on a blood thinner, call your care team promptly about unusual bruising, red or brown urine, red or black stools, or a nosebleed or gum bleeding that does not stop. Call 911 right away for signs of a stroke: sudden drooping, numbness or weakness of the face, arm or leg on one side, sudden confusion or trouble speaking, sudden loss of vision, sudden trouble walking or loss of balance, or a sudden severe headache. A suddenly cold, pale, painful or numb arm or leg, or sudden severe belly pain, can also mean a clot has blocked an artery and needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Non-Infective Endocarditis is like, what's helped you, or ask the community a question.